1. Home
  2. CGC vs EYPT Comparison

CGC vs EYPT Comparison

Compare CGC & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canopy Growth Corporation

CGC

Canopy Growth Corporation

N/A

Current Price

$0.43

Market Cap

299.0M

Sector

Health Care

ML Signal

N/A

EYPT

EyePoint Pharmaceuticals Inc.

N/A

Current Price

$0.23

Market Cap

273.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CGC
EYPT
Founded
N/A
1987
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
299.0M
273.3M
IPO Year
2023
2005

Fundamental Metrics

Financial Performance
Metric
CGC
EYPT
Price
$0.43
$0.23
Analyst Decision
Hold
Analyst Count
0
13
Target Price
N/A
★ $8.31
AVG Volume (30 Days)
2.5M
★ 5.8M
Earning Date
11-06-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 84.17
N/A
EPS
★ N/A
N/A
Revenue
★ $12,759,000.00
$7,539,000.00
Revenue This Year
$18.91
N/A
Revenue Next Year
$6.82
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$0.26
52 Week High
$2.38
$19.11

Technical Indicators

Market Signals
Indicator
CGC
EYPT
Relative Strength Index (RSI) 19.41 16.61
Support Level N/A N/A
Resistance Level $1.08 $3.57
Average True Range (ATR) 0.05 0.04
MACD -0.01 0.13
Stochastic Oscillator 0.54 2.11

Price Performance

Historical Comparison
CGC
EYPT

About CGC Canopy Growth Corporation

Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

Share on Social Networks: